Litcius/Paper detail

NF-κB Inhibitory and Antibacterial Helvolic and Fumagillin Derivatives from <i>Aspergillus terreus</i>

KH Ahammad Uz Zaman, Zhenquan Hu, Xiaohua Wu, Shaobin Hou, Jennifer A. Saito, Tamara P. Kondratyuk, John M. Pezzuto, Shugeng Cao

2020Journal of Natural Products24 citationsDOI

Abstract

Two new helvolic acid analogues (1 and 2) and one new fumagillin derivative containing an octahydroisobenzofuran moiety (3), together with four known compounds (4–7), were isolated from an Aspergillus terreus, isolated from soil collected from Mauna Kea, the highest mountain in Hawaii. Compound 4 was recorded in SciFinder with a CAS Registry Number of 1379525-35-5, but it was not documented in the cited reference (ACS Chem. Biol. 2012, 7, 137). The structures of compounds 1–4 were elucidated by NMR spectroscopy and HRMS and ECD analysis. Compounds 5 and 6 showed significant inhibitory activity against NF-κB with IC50 values of 2.7 ± 2.6 and 6.5 ± 0.8 μM, respectively. Compounds 1 and 2 were active against S. aureus with MICs of 6.25 and 6.25 μg/mL, respectively, while compound 5 inhibited E. coli with an MIC of 3.12 μg/mL.

Topics & Concepts

Aspergillus terreusFumagillinStereochemistryMoietyChemistryAntibacterial activityMinimum inhibitory concentrationAspergillusIC50Derivative (finance)Nuclear magnetic resonance spectroscopyBiologyMicrobiologyBiochemistryIn vitroBacteriaAngiogenesisFinancial economicsEconomicsGeneticsCancer researchMicrobial Natural Products and BiosynthesisFungal Biology and ApplicationsPhytochemical compounds biological activities